NXTC

NASD NextCure, Inc.
Oct 11, 2026 · 8:33 AM ET EOD Market Closed

$7.18 ↑ +0.00 (+0.00%) Trading Up from the previous close of $7.18, $0.02 below the day’s high of $7.20

YTD change
-49.40%
vs 20-day SMA
+27.41%
vs 200-day SMA
-14.77%

Price ranges

Previous day
$6.30 $7.20
open $6.77 close $7.18
+$0.41 (+6.06%)
Today
$6.30 $7.20
$7.18
Past week
$4.85 $6.94
from $4.96 now $7.18
+$2.22 (+44.76%)
Past month
$4.64 $7.78
from $7.31 now $7.18
-$0.13 (-1.78%)
This year
$1.55 $14.65
from $14.19 now $7.18
-$7.01 (-49.40%)

Price & Performance

-5.14 (-41.72%) / 6M

$0.7064$5.03$9.34$13.66Apr 13Jul 13Oct 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 99.5% away from all-time highs of $1,308.00
  • NXTC is down 49% since the beginning of the year
  • NXTC is up 10% over the past 12 months
  • NXTC is down 2% over the past 1 month
  • 2% of all NXTC investors are betting against NXTC

NXTC reads very good: price sits above one of the two key moving averages, the 12-month move is +13.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-2.8
Earnings momentum -211.1% Quarterly EPS growth
Quarterly change -211.1%

Valuation

P/E ratio N/A
Enterprise value $20.2M
Beta 2.35

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$20.1M
Debt$4.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $32.9M

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $414.87 +1.82%
MRNA Moderna, Inc. $225.00 +14.21%
RVMD Revolution Medicines, Inc. $189.76 +0.87%
ROIV Roivant Sciences Ltd. $35.44 +3.60%
BNTX BioNTech SE Sponsored ADR $96.96 +5.32%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.